Gout, Urate, and Crystal Deposition Disease | Aims Update
27 January 2025
To further enhance the quality of Gout, Urate, and Crystal Deposition Disease (GUCDD, ISSN: 2813-4583) and the papers published in it, under the guidance of our Editors-in-Chief, Dr. Tony Merriman and Prof. Dr. Tristan Pascart the journal has updated and revised its aims. The original aim and the updated version are listed below:
| Aims (new version): Gout, Urate, and Crystal Deposition Disease (ISSN 2813-4583) is an international, open access, peer review journal on gout, urate, and crystal deposition disease. GUCDD publishes reviews, regular research papers (articles), short communications, brief reports, technical notes, perspectives and conference reports. We do not accept case reports. There is no restriction on the maximum length of the papers. Full experimental details must be provided so that results can be reproduced. Gout and crystal deposition-associated disorders are among the leading causes of inflammation and arthritis throughout the world, with gout being the most common form of inflammatory arthritis affecting adults. Historically referred to as “the disease of kings,” the causes and mechanisms of gout, its comorbidities, and related crystal-deposition diseases have been poorly understood over the centuries. Recently, however, research in this field has markedly expanded. The growth of this work has been in step with the increased prevalence and awareness of inflammatory crystal-associated diseases globally, as well as the recognition that the common disorder hyperuricemia is directly linked with not only gouty arthritis but also implicated in diseases of major organ systems. Concurrently, the field has expanded to include more disciplines, including genomics, nephrology, cardiology, endocrinology, urology, and advanced imaging. This journal is intended both for researchers and for clinicians who are actively managing patients. Readers and authors will be particularly interested in the epidemiology, pathophysiology, imaging, diagnosis, treatment, and outcomes of gout, hyperuricemia, degenerative and inflammatory calcium crystal arthropathies (including calcium pyrophosphate and basic calcium phosphate crystal deposition disease). In addition, readers and authors will include those interested in crystal deposition disorders that involve not only the joint, but also renal, vascular, and other extra-articular tissues. The journal will publish high quality, basic-translational and clinical-translational studies, including clinical trials. In addition, the G-CAN annual research symposium abstracts and a wide array of reviews and editorials will be published in this journal. The range of investigative work presented in the journal will not only be international, but also both inter- and multi-disciplinary. Major sources of published works will include clinicians such as rheumatologists, nephrologists, cardiologists, endocrinologists and orthopedists, and researchers in epidemiology, genomics, bioinformatics, other data sciences, and advanced imaging. |
Aims (old version): Gout, Urate, and Crystal Deposition Disease (ISSN 2813-4583) is an international, open access journal on gout, urate, and crystal deposition disease. GUCDD publishes reviews, regular research papers (articles) and short communications. Gout and crystal deposition-associated disorders are among the leading causes of inflammation and arthritis throughout the world, with gout being the most common form of inflammatory arthritis affecting adults. Historically referred to as “the disease of kings”, the causes and mechanisms of gout, its comorbidities, and related crystal-deposition diseases have been poorly understood over the centuries. Recently, however, research in this field has markedly expanded. The growth of this work has been in step with the increased prevalence and awareness of inflammatory crystal-associated diseases globally, as well as the recognition that the common disorder hyperuricemia is directly linked with not only gouty arthritis but also implicated in diseases of major organ systems. Concurrently, the field has expanded to include more disciplines, including genomics, nephrology, cardiology, endocrinology, urology, and advanced imaging. This journal is intended both for researchers and for clinicians who are actively managing patients. Readers and authors will be particularly interested in the epidemiology, pathophysiology, imaging, diagnosis, treatment, and outcomes of gout, hyperuricemia, degenerative and inflammatory calcium crystal arthropathies (including calcium pyrophosphate and basic calcium phosphate crystal deposition disease). In addition, readers and authors will include those interested in crystal deposition disorders that involve not only the joint, but also renal, vascular, and other extra-articular tissues. The journal will publish high quality, basic-translational and clinical-translational studies, including clinical trials. In addition, the G-CAN annual research symposium abstracts and a wide array of reviews and editorials will be published in this journal. The range of investigative work presented in the journal will not only be international, but also both inter- and multi-disciplinary. Major sources of published works will include clinicians such as rheumatologists, nephrologists, cardiologists, endocrinologists and orthopedists, and researchers in epidemiology, genomics, bioinformatics, other data sciences, and advanced imaging. |
For more detailed information, please visit the following link: https://www.mdpi.com/journal/gucdd/about.
GUCDD Editorial Office